“Altered Threonine Tyrosine Kinase (TTK) Expression Is Associated With Adverse Clinical Outcomes in Breast Tumors: An in Silico Approach”. Research, Society and Development, vol. 12, no. 13, Nov. 2023, p. e40121344285, https://doi.org/10.33448/rsd-v12i13.44285.